Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CHKA | P35790 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3795193 | 1.00 | CA2 (0.38) | CA2CHKACYP1A2MAPK1SMN1; SMN2 | |
| SCHEMBL28474543 | 0.91 | — | — | |
| SCHEMBL3237370 | 0.82 | L3MBTL1 (0.39) | CA2CHKASMN1; SMN2GAACHRM5 | |
| SCHEMBL9174365 | 0.80 | CYP1A2 (0.33) | CA2CHKACYP1A2MAPK1SMN1; SMN2 | |
| SCHEMBL11952841 | 0.79 | CHRM5 (0.34) | CA2CHKAHTTCHRM5CHRM3 | |
| SCHEMBL3867732 | 0.75 | HSD17B10 (0.45) | HSD17B10CHRM5CHRM3SIGMAR1ALDH1A1 | |
| SCHEMBL27632519 | 0.73 | MAPT (0.50) | CA2CHKACYP1A2MAPK1SMN1; SMN2 | |
| SCHEMBL15824158 | 0.73 | — | — | |
| Carbamic Acid SCHEMBL3170790 | 0.72 | SMN1; SMN2 (0.32) | CA2CHKASMN1; SMN2 | |
| Piperidine SCHEMBL9367108 | 0.71 | GAA (0.47) | CA2CHKACYP1A2MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011151436-A2 | NOVEL COMPOUNDS, METHOD FOR USE THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | EUROSCREEN S.A. (BE) | 2011-12-08 | — | — | WO | claimed |